ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,294.10
-0.42%
S&P ASX All Technology
3,845.90
-0.28%
Brent Oil
78.395
1.91%
US Dollar vs AUD
1.61713
0.09%
Bitcoin
94,939.42
2.74%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. INVO BioScience Inc (INVO)

  7. INVO BioScience Inc (INVO) News

INVO

INVO BioScience (INVO)

INVO BioScience Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INVO
DateTimeSourceHeadlineSymbolCompany
25/10/202400:00GlobeNewswire Inc.NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular CarcinomaNASDAQ:INVOINVO BioScience Inc
23/10/202403:05Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:INVOINVO BioScience Inc
22/10/202400:00GlobeNewswire Inc.INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA BiosciencesNASDAQ:INVOINVO BioScience Inc
16/10/202400:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
15/10/202400:18GlobeNewswire Inc.INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)NASDAQ:INVOINVO BioScience Inc
02/10/202407:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
21/09/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
19/09/202407:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
15/08/202406:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
14/08/202423:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INVOINVO BioScience Inc
14/08/202423:00GlobeNewswire Inc.INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDANASDAQ:INVOINVO BioScience Inc
22/05/202406:39Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INVOINVO BioScience Inc
16/05/202406:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
16/05/202406:15GlobeNewswire Inc.INVO Reports Record First Quarter 2024 Financial ResultsNASDAQ:INVOINVO BioScience Inc
07/05/202407:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
18/04/202400:25AllPennyStocks.comMicro Cap Massively Bid Up Before Opening BellNASDAQ:INVOINVO BioScience Inc
17/04/202406:59GlobeNewswire Inc.INVO Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:INVOINVO BioScience Inc
07/02/202402:24Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INVOINVO BioScience Inc
02/02/202401:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
24/01/202400:00GlobeNewswire Inc.NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)NASDAQ:INVOINVO BioScience Inc
18/01/202400:00GlobeNewswire Inc.INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board DirectorsNASDAQ:INVOINVO BioScience Inc
17/01/202409:29Edgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:INVOINVO BioScience Inc
11/01/202408:46Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:INVOINVO BioScience Inc
11/01/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
04/01/202409:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
29/12/202309:04Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:INVOINVO BioScience Inc
29/12/202309:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
14/12/202309:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INVOINVO BioScience Inc
14/12/202308:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
12/12/202300:00PR Newswire (US)NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood JournalNASDAQ:INVOINVO BioScience Inc
 Showing the most relevant articles for your search:NASDAQ:INVO

Your Recent History

COIN
ETHUSD
Ethereum
ASX
WBC
Westpac Banking
FX
AUDCAD
AUD vs CAD
CCOM
SILVER
SILVER
NASDAQ
NVDA
NVIDIA
NASDAQ
MSFT
Microsoft
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
CSL
CSL
ASX
WOW
Woolworths
ASX
RIO
Rio Tinto
SPI
SP500
S&P 500
NYSE
MCD
McDonalds
ASX
MQG
Macquarie
ASX
NAB
National Australia Bank
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads